R
Rama Shanker Verma
Researcher at Indian Institute of Technology Madras
Publications - 167
Citations - 3945
Rama Shanker Verma is an academic researcher from Indian Institute of Technology Madras. The author has contributed to research in topics: Stem cell & Mesenchymal stem cell. The author has an hindex of 30, co-authored 159 publications receiving 3160 citations. Previous affiliations of Rama Shanker Verma include University of Pennsylvania & Thapar University.
Papers
More filters
Journal ArticleDOI
The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine.
L Praveen Kumar,Sangeetha Kandoi,Ranjita Misra,S. Vijayalakshmi,Kalyanaraman Rajagopal,Rama Shanker Verma +5 more
TL;DR: This review will focus on the accumulating evidence that points to the therapeutic potential of the conditioned medium, both from pre-clinical and clinical studies, and the importance of profiling the conditionedmedium for assessing its potential for cell-free therapy therapy.
Journal ArticleDOI
Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives
Antara Banerjee,Surajit Pathak,Vimala Devi Subramanium,G Dharanivasan,Ramachandran Murugesan,Rama Shanker Verma +5 more
TL;DR: The present review focuses on recent approaches for colon-specific drug delivery (CDDS) and aims to unveil the emerging possibilities and advances in the treatment of CC with CDDS.
Journal ArticleDOI
Nanomaterials for early detection of cancer biomarker with special emphasis on gold nanoparticles in immunoassays/sensors.
TL;DR: The recent advancements in immunosensing techniques that were developed exploiting the unique properties of gold nanoparticles are explored and the possible future trends with respect to gold nanoparticle-coupled microfluidic sensors; paper based analytical devices and the single-molecule biosensing are discussed.
Journal ArticleDOI
Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy
TL;DR: A novel generation of immunotoxins in which the cytotoxic moiety is an endogenous protein of human origin like proapoptotic protein or RNase has been developed, and a review summarizes the advances in this new class of fusion protein and the future directions to be explored.
Journal ArticleDOI
An improved protocol for primary culture of cardiomyocyte from neonatal mice
TL;DR: An improved method for rapid isolation of cardiomyocytes from neonatal mice, as well as the maintenance and propagation of such cultures for the long term is described.